British American Tobacco (BATS)

Sector:

Tobacco

Index:

FTSE 100

2,917.50p
   
  • Change Today:
    -44.00p
  • 52 Week High: 3,619.00
  • 52 Week Low: 2,375.00
  • Currency: UK Pounds
  • Shares Issued: 2,293.81m
  • Volume: 7,429,576
  • Market Cap: £66,922m
  • RiskGrade: 147

Tobacco stocks rise after FDA boss Gottlieb quits

By Oliver Haill

Date: Wednesday 06 Mar 2019

LONDON (ShareCast) - (Sharecast News) - Shares in tobacco companies rose on Wednesday after America's chief drug and tobacco regulator unexpectedly resigned overnight.
Scott Gottlieb, who as Commissioner of the US Food & Drug Administration had been spearheading a ban on menthol cigarettes and curbs on e-cigarettes, is expected to leave in April, less than two years since he started in the role.

Gottlieb, who said he was quitting to spend more time with his family, had driven the FDA to speed up the process of approving new drugs and focused on lowering drug costs by easing approvals for generic versions of drugs that did not have much competition previously - such as seen in the case of Indivior's Suboxone Film.

President Trump said in a tweet that Gottlieb "has helped us to lower drug prices, get a record number of generic drugs approved and onto the market, and so many other things. He and his talents will be greatly missed".

Analyst Nico von Stackelberg at Liberum said Gottlieb "has had a huge impact" on US public health policy and it thought that the Tobacco Products division is "clearly moving down a path towards greater restrictions over combustible cigarettes and more recently, flavoured e-cigarettes".

However, he added: "If the probability of a menthol ban and nicotine standard were say 75%, we wouldn't say this takes the probability of it going through much below 70%. We won't change our estimates because we do not know who is taking over yet or if this appointee has a new strategic direction for the FDA."

He added that he did not think a substantial share price swing in the UK tobacco companies is warranted without greater clarity on any changes to the tobacco control path.



Analysts at Deutsche Bank, taking press reports of the esteem at which the current administration held Gottlieb at face value, expect a like-minded replacement.

As it relates to the US tobacco industry, the change in FDA leadership "puts up for debate what the agency has been discussing and exploring as Commissioner Gottlieb has become synonymous with the actions of the FDA", but it was not clear if its was controversy over any aspect of the multifaceted FDA controversies had led to his departure.

London-quoted British American Tobacco and Imperial Brands both saw their shares rise on Wednesday, while overnight US-quoted 22nd Century Group, which is focused on nicotine reduction, lost nearly 30% of its value.

Indivior was higher, generic drugmaker Hikma was flat.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BATS Market Data

Currency UK Pounds
Share Price 2,917.50p
Change Today -44.00p
% Change -1.49 %
52 Week High 3,619.00
52 Week Low 2,375.00
Volume 7,429,576
Shares Issued 2,293.81m
Market Cap £66,922m
RiskGrade 147

BATS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
51.2% below the market average51.2% below the market average51.2% below the market average51.2% below the market average51.2% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
91.19% above the market average91.19% above the market average91.19% above the market average91.19% above the market average91.19% above the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
55.17% above the market average55.17% above the market average55.17% above the market average55.17% above the market average55.17% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 14
Buy 0
Neutral 4
Sell 1
Strong Sell 1
Total 20
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BATS Dividends

  Latest Previous
  Q4 Q3
Ex-Div 24-Dec-19 03-Oct-19
Paid 06-Feb-20 14-Nov-19
Amount 50.75p 50.75p

Trades for 20-Sep-2019

Time Volume / Share Price
17:03 150,000 @ 2,915.18p
16:43 1,300 @ 2,913.00p
16:43 6,505 @ 2,908.17p
16:35 3,742,475 @ 2,917.50p
16:30 1,324 @ 2,908.65p

BATS Key Personnel

Chair Richard Burrows
CEO Jack Bowles
Finance Director Tadeu Marroco

Top of Page